Soluble ligands for the NKG2D receptor are released during HIV‐1 infection and impair NKG2D expression and cytotoxicity of NK cellsGiulia Matusali, Margherita Doria, Anna Rita Buonomini et al.|The FASEB Journal|2013Cited by 88
Maraviroc as Intensification Strategy in HIV-1 Positive Patients with Deficient Immunological Response: an Italian Randomized Clinical TrialStefano Rusconi, Giulia Marchetti, Elisa Colella et al.|PLoS ONE|2013Cited by 42
HIV-1 Residual Viremia and Proviral DNA in Patients with Suppressed Plasma Viral Load ( < 400 HIV-RNA cp/ml) During Different Antiretroviral RegimensEmanuele Nicastri, Massimo Andreoni, Lucia Palmisano et al.|Current HIV Research|2008Cited by 32
HIV Coreceptor Tropism in Paired Plasma, Peripheral Blood Mononuclear Cell, and Cerebrospinal Fluid Isolates from Antiretroviral-Naïve SubjectsSaverio Giuseppe Parisi, Massimo Andreoni, Carolina Andreoni et al.|Journal of Clinical Microbiology|2011Cited by 29
Cellular HIV‐1 DNA quantitation in patients during simplification therapy with protease inhibitor‐sparing regimensLoredana Sarmati, Massimo Andreoni, Saverio Giuseppe Parisi et al.|Journal of Medical Virology|2007Cited by 23